Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Broersen

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Occupational and Environmental Medicine|June 5, 2003
Measurement quality and validity of the "need for recovery scale"M van Veldhoven, S Broersen
Journal of Virology|January 1, 1995
Equal levels of gp120 retention and neutralization resistance of phenotypically distinct primary human immunodeficiency virus type 1 variants upon soluble CD4 treatmentM Groenink, J P Moore, S Broersen, et al.
Journal of Virology|October 3, 2001
Cytopathic effects of non-syncytium-inducing and syncytium-inducing human immunodeficiency virus type 1 variants on different CD4(+)-T-cell subsets are determined only by coreceptor expressionD Kwa, J Vingerhoed, B Boeser-Nunnink, et al.
AIDS (London, England)|July 14, 1998
The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infectionR P van Rij, S Broersen, J Goudsmit, et al.
AIDS Research and Human Retroviruses|January 20, 1997
Potent inhibition of replication of primary HIV type 1 isolates in peripheral blood lymphocytes by negatively charged human serum albuminsM Groenink, P J Swart, S Broersen, et al.
The Journal of Infectious Diseases|September 9, 1999
Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progressionA M de Roda Husman, R P van Rij, H Blaak, et al.
Journal of Virology|February 13, 2001
Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical courseT Beaumont, A van Nuenen, S Broersen, et al.
International Archives of Occupational and Environmental Health|January 1, 1990
Work hygienic behaviour as modifier of the lead air-lead blood relationP Ulenbelt, M E Lumens, H M Géron, et al.
Human Genetics|July 1, 1991
New distal marker closely linked to the fragile X locusT J Hulsebos, B A Oostra, S Broersen, et al.
Journal of Virology|August 10, 2000
Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzeesT Beaumont, S Broersen, A van Nuenen, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Occupational and Environmental Medicine|June 5, 2003
Measurement quality and validity of the "need for recovery scale"M van Veldhoven, S Broersen
Journal of Virology|January 1, 1995
Equal levels of gp120 retention and neutralization resistance of phenotypically distinct primary human immunodeficiency virus type 1 variants upon soluble CD4 treatmentM Groenink, J P Moore, S Broersen, et al.
Journal of Virology|October 3, 2001
Cytopathic effects of non-syncytium-inducing and syncytium-inducing human immunodeficiency virus type 1 variants on different CD4(+)-T-cell subsets are determined only by coreceptor expressionD Kwa, J Vingerhoed, B Boeser-Nunnink, et al.
AIDS (London, England)|July 14, 1998
The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infectionR P van Rij, S Broersen, J Goudsmit, et al.
AIDS Research and Human Retroviruses|January 20, 1997
Potent inhibition of replication of primary HIV type 1 isolates in peripheral blood lymphocytes by negatively charged human serum albuminsM Groenink, P J Swart, S Broersen, et al.
The Journal of Infectious Diseases|September 9, 1999
Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progressionA M de Roda Husman, R P van Rij, H Blaak, et al.
Journal of Virology|February 13, 2001
Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical courseT Beaumont, A van Nuenen, S Broersen, et al.
International Archives of Occupational and Environmental Health|January 1, 1990
Work hygienic behaviour as modifier of the lead air-lead blood relationP Ulenbelt, M E Lumens, H M Géron, et al.
Human Genetics|July 1, 1991
New distal marker closely linked to the fragile X locusT J Hulsebos, B A Oostra, S Broersen, et al.
Journal of Virology|August 10, 2000
Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzeesT Beaumont, S Broersen, A van Nuenen, et al.
Pageof 2